NDC 48433-307-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48433-307
- Requested NDC
- 48433-307-01
- Package NDCs from labels
- 48433-307-01, 48433-307-10
- Manufacturer
- Safecor Health, LLC
- Effective date
- 2014-08-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Safecor Health, LLC | Safecor Health, LLC | 2014-08-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Direct_Rx | 0b286fd1-8179-d87a-e063-6294a90a2f23 | 2026-03-05 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| cle de peau BEAUTE RADIANT FLUID FOUNDATION NATURAL B50 | OCTINOXATE AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | 4490f968-46b6-44d2-af2d-5130b52c8861 | 2026-03-05 | Warnings | 15FIX9V2JP |
| Calamine | CALAMINE, PRAMOXINE HCL | Amazon.com Services LLC | aceb0b10-8c90-4a06-8c47-cd1a2b4676a3 | 2026-03-03 | Warnings, Adverse reactions | 1K09F3G675 |
| Gabapentin | GABAPENTIN | American Health Packaging | e00f5048-1a06-44f4-b244-aa2755f4be22 | 2026-03-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Calamine | FERRIC OXIDE RED | Old East Main Co. | c38c77fd-abbf-4c87-a9c0-a0e21ed3f97d | 2026-03-02 | Warnings, Adverse reactions | 1K09F3G675 |
| Gabapentin | GABAPENTIN | Solco Healthcare US, LLC | 360d953b-4313-45ae-b933-296547d4577d | 2026-02-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Calamine | FERRIC OXIDE RED | Chain Drug Marketing Association | 86ff4875-9007-4b7b-8f46-16cbd475d4bb | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Chain Drug Marketing Association | 6c848b98-f01c-40f2-a9aa-2af76cb370c8 | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Levico Prunus | LEVICO PRUNUS | Uriel Pharmacy Inc. | 63db9374-8ee2-48cf-8799-454c95869808 | 2026-02-27 | Warnings | 1K09F3G675 |
| TIBENA EVERY DAY REAL SUN BLOCK | TITANIUM DIOXIDE, ZINC OXIDE | KONAD CO LTD | 211c9930-4f91-cf8f-e063-6394a90a97b3 | 2026-02-26 | Warnings | 15FIX9V2JP |
| CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION MATTE M B10 | TITANIUM DIOXIDE | Shiseido Americas Corporation | 54f8210f-4934-4ada-89c3-aa89e7a09260 | 2026-02-26 | Warnings | 15FIX9V2JP |
| SHISEIDO UV PROTECTIVE COMPACT (REFILL) FAIR IVORY | OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | c05cef12-a6a7-4682-9357-6d77f4ca3267 | 2026-02-25 | Warnings | 15FIX9V2JP |
| cle de peau BEAUTE RADIANT FOUNDATION N M I10 | OCTINOXATE AND TITANIUM DIOXIDE | Shiseido Americas Corporation | 3be1fe06-bd3b-4078-bee9-d3caf8d068ff | 2026-02-25 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 54c09aa5-6724-480a-a115-c88484e39e93 | 2026-02-24 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | 401b30fc-e143-4906-aae1-e5b5c190d4a8 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | bfee67dc-d2b1-4a00-92d9-a42be3189c74 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| cle de peau BEAUTE THE FOUNDATION N M O20 | OCTINOXATE AND TITANIUM DIOXIDE | Shiseido Americas Corporation | 9507f6d1-c11c-428d-8d95-b436f27ba26a | 2026-02-24 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Family Dollar Stores, Inc | 1a03331e-3676-451c-be22-9a547e8ae6e2 | 2026-02-24 | Warnings, Adverse reactions | 1K09F3G675 |
| Perfect Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | SKIN PERFECT MEDICAL | 4b93538a-3b3e-90f7-e063-6294a90ab898 | 2026-02-24 | Warnings | 15FIX9V2JP |
| ANTI-AGING TINTED SUNSCREEN | TITANIUM DIOXIDE, ZINC OXIDE | LASER GIRL SKINCARE, LLC | 4b93cd22-1289-29bc-e063-6294a90ab781 | 2026-02-24 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.